|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-21
|
|
pubmed:abstractText |
Osteonecrosis of the jaw (ONJ) is a well-described complication of bisphosphonates use in patients with multiple myeloma (MM). We investigated whether the occurrence of ONJ decreased after the implementation of preventive measures in 128 patients with MM who received zoledronic acid.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:BamiaCC,
pubmed-author:BamiasAA,
pubmed-author:ChristoulasDD,
pubmed-author:DimopoulosM AMA,
pubmed-author:Eleftherakis-PapaiakovouEE,
pubmed-author:GikaDD,
pubmed-author:KastritisEE,
pubmed-author:MelakopoulosII,
pubmed-author:MigkouMM,
pubmed-author:RoussonDD,
pubmed-author:TerposEE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
117-20
|
|
pubmed:dateRevised |
2009-8-10
|
|
pubmed:meshHeading |
pubmed-meshheading:18689864-Adult,
pubmed-meshheading:18689864-Aged,
pubmed-meshheading:18689864-Aged, 80 and over,
pubmed-meshheading:18689864-Antineoplastic Agents,
pubmed-meshheading:18689864-Bone Density Conservation Agents,
pubmed-meshheading:18689864-Boronic Acids,
pubmed-meshheading:18689864-Dental Prophylaxis,
pubmed-meshheading:18689864-Diphosphonates,
pubmed-meshheading:18689864-Female,
pubmed-meshheading:18689864-Humans,
pubmed-meshheading:18689864-Imidazoles,
pubmed-meshheading:18689864-Incidence,
pubmed-meshheading:18689864-Jaw Diseases,
pubmed-meshheading:18689864-Male,
pubmed-meshheading:18689864-Middle Aged,
pubmed-meshheading:18689864-Multiple Myeloma,
pubmed-meshheading:18689864-Osteonecrosis,
pubmed-meshheading:18689864-Pyrazines,
pubmed-meshheading:18689864-Retrospective Studies,
pubmed-meshheading:18689864-Thalidomide,
pubmed-meshheading:18689864-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, Medical School, University of Athens, Greece. mdimop@med.uoa.gr
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
